Mural Oncology Ownership | Who Owns Mural Oncology?


OverviewFinancialsChart

Mural Oncology Ownership Summary


Mural Oncology is owned by 16.22% institutional investors, 13.17% insiders, and 70.61% retail investors. Solas capital management is the largest institutional shareholder, holding 5.24% of MURA shares.

MURA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockMural Oncology16.22%13.17%70.61%
SectorHealthcare Stocks 279.19%10.58%-189.76%
IndustryBiotech Stocks 63.97%10.68%25.35%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Solas capital management888.00K5.24%$1.12M
Prosight management, lp422.74K2.49%$532.66K
Millennium management169.00K1.00%$212.94K
Jane street group---
Northwestern mutual wealth management---
Squarepoint ops---
Virtu financial---
Cranbrook wealth management---
Ronald blue trust---
Knights of columbus asset advisors---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Solas capital management888.00K0.63%$1.12M
Prosight management, lp422.74K0.17%$532.66K
Millennium management169.00K0.00%$212.94K
Jane street group---
Northwestern mutual wealth management---
Squarepoint ops---
Virtu financial---
Cranbrook wealth management---
Ronald blue trust---
Knights of columbus asset advisors---

Top Buyers

HolderShares% AssetsChange
Millennium management169.00K0.00%746.00
Cranbrook wealth management---4.00
Ronald blue trust---6.00
Northwestern mutual wealth management---10.00
Knights of columbus asset advisors---10.00

Top Sellers

HolderShares% AssetsChange
Solas capital management888.00K0.63%-381.00K
Squarepoint ops---175.50K
Nicollet investment management---94.74K
Alpine global management---80.96K
Prosight management, lp422.74K0.17%-44.08K

Sold Out

HolderChange
Cranbrook wealth management-4.00
Ronald blue trust-6.00
Knights of columbus asset advisors-10.00
Northwestern mutual wealth management-10.00
Cubist systematic strategies-40.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20254-94.59%2,749,454-70.69%160.54%1-96.15%3-86.96%
Dec 31, 2024745.71%9,381,197-1.48%541.76%2618.18%23-11.54%
Sep 30, 202470-14.63%9,521,654-12.63%551.35%22-31.25%26-16.13%
Jun 30, 202482-14.58%10,897,815-9.88%641.24%326.67%31-34.04%
Mar 31, 202496-20.66%12,092,738-9.53%721.12%30-75.00%47-

Recent Insider Transactions


DateNameRoleActivityValue
Mar 04, 2025Keson-Brookes Maiken See RemarksSell$4.24K
Mar 05, 2025Keson-Brookes Maiken See RemarksSell$5.07K
Mar 04, 2025Loew Caroline Chief Executive OfficerSell$14.49K
Feb 24, 2025Goodman Vicki L Chief Medical OfficerSell$51.29K
Dec 23, 2024Keson-Brookes Maiken See RemarksSell$8.35K

Insider Transactions Trends


DateBuySell
2025 Q1-4
2024 Q4-4
2024 Q312
2023 Q4--

MURA Ownership FAQ


Who Owns Mural Oncology?

Mural Oncology shareholders are primarily institutional investors at 16.22%, followed by 13.17% insiders and 70.61% retail investors. The average institutional ownership in Mural Oncology's industry, Biotech Stocks , is 63.97%, which Mural Oncology falls below.

Who owns the most shares of Mural Oncology?

Mural Oncology’s largest shareholders are Solas capital management (888K shares, 5.24%), Prosight management, lp (422.74K shares, 2.49%), and Millennium management (169K shares, 1.00%). Together, they hold 8.73% of Mural Oncology’s total shares outstanding.

Does Blackrock own Mural Oncology?

BlackRock is not among the top 10 institutional shareholders of Mural Oncology.

Who is Mural Oncology’s biggest shareholder by percentage of total assets invested?

Solas capital management is Mural Oncology’s biggest shareholder by percentage of total assets invested, with 0.63% of its assets in 888K Mural Oncology shares, valued at 1.12M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools